As of 2025-11-14, the EV/EBITDA ratio of Transgene SA (TNG.PA) is -5.87. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TNG.PA's latest enterprise value is 187.70 mil EUR. TNG.PA's TTM EBITDA according to its financial statements is -31.99 mil EUR. Dividing these 2 quantities gives us the above TNG.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.6x - 9.5x | 8.9x |
| Forward P/E multiples | 10.8x - 14.1x | 12.1x |
| Fair Price | (2.72) - (2.39) | (2.63) |
| Upside | -307.4% - -282.7% | -301.1% |
| Date | EV/EBITDA |
| 2025-11-12 | -5.58 |
| 2025-11-11 | -5.56 |
| 2025-11-10 | -5.33 |
| 2025-11-07 | -5.35 |
| 2025-11-06 | -5.47 |
| 2025-11-05 | -5.95 |
| 2025-11-04 | -6.55 |
| 2025-11-03 | -6.07 |
| 2025-10-31 | -5.99 |
| 2025-10-30 | -5.91 |
| 2025-10-29 | -5.83 |
| 2025-10-28 | -6.12 |
| 2025-10-27 | -5.99 |
| 2025-10-24 | -6.03 |
| 2025-10-23 | -6.01 |
| 2025-10-22 | -5.85 |
| 2025-10-21 | -6.05 |
| 2025-10-20 | -6.03 |
| 2025-10-17 | -5.78 |
| 2025-10-16 | -5.95 |
| 2025-10-15 | -5.91 |
| 2025-10-14 | -5.91 |
| 2025-10-13 | -5.74 |
| 2025-10-10 | -5.66 |
| 2025-10-09 | -5.62 |
| 2025-10-08 | -5.35 |
| 2025-10-07 | -5.02 |
| 2025-10-06 | -5.04 |
| 2025-10-03 | -5.02 |
| 2025-10-02 | -5.12 |
| 2025-10-01 | -5.12 |
| 2025-09-30 | -5.20 |
| 2025-09-29 | -5.16 |
| 2025-09-26 | -5.24 |
| 2025-09-25 | -5.12 |
| 2025-09-24 | -5.08 |
| 2025-09-23 | -5.29 |
| 2025-09-22 | -5.29 |
| 2025-09-19 | -5.29 |
| 2025-09-18 | -5.24 |
| 2025-09-17 | -5.18 |
| 2025-09-16 | -5.00 |
| 2025-09-15 | -5.22 |
| 2025-09-12 | -5.49 |
| 2025-09-11 | -5.20 |
| 2025-09-10 | -5.10 |
| 2025-09-09 | -4.95 |
| 2025-09-08 | -4.95 |
| 2025-09-05 | -5.00 |
| 2025-09-04 | -5.02 |